Effect of Ca (II) ion on the in vitro availability and protein binding of Amlodipine besylate

Drug-metal complex might, therefore, decrease the free drug in plasma and tissue systems. This may change the pharmacokinetic properties of the drug and may affect the pharmacological effects. It is thus inferred that care and monitoring must be taken during combination therapy of Amlodipine besylate and Ca2+.